Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Galactomannan enzymatic immunoassay cross-reactivity caused by Prototheca species.

Literature DB >> 22837317

Galactomannan enzymatic immunoassay cross-reactivity caused by Prototheca species.

D Van den Bossche¹, A De Bel, M Hendrickx, A De Becker, R Jacobs, A Naessens, D Piérard.

Abstract

We report a reactive Aspergillus galactomannan enzymatic immunoassay against the serum of a patient with invasive Prototheca zopfii infection. Analysis of the supernatants of suspensions of P. zopfii and other Prototheca isolates revealed positive results as well. These data suggest cross-reactivity with the serum Aspergillus galactomannan assay in invasive protothecosis.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2012 PMID： 22837317 PMCID： PMC3457419 DOI： 10.1128/JCM.01028-12

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

22 in total

1. False-positive results of Aspergillus enzyme-linked immunosorbent assay in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation.

Authors: T Hamaki; M Kami; Y Kanda; S Miyakoshi; J Ueyama; S Morinaga; Y Mutou
Journal: Bone Marrow Transplant Date: 2001-09 Impact factor: 5.483

2. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan.

Authors: C M Swanink; J F Meis; A J Rijs; J P Donnelly; P E Verweij
Journal: J Clin Microbiol Date: 1997-01 Impact factor: 5.948

3. Detection of Aspergillus galactomannan antigen in foods and antibiotics.

Authors: R Ansorg; R van den Boom; P M Rath
Journal: Mycoses Date: 1997-12 Impact factor: 4.377

4. Aspergillus galactomannan enzyme-linked immunosorbent assay cross-reactivity caused by invasive Geotrichum capitatum.

Authors: Mareva Giacchino; Nadia Chiapello; Stefania Bezzio; Franca Fagioli; Paola Saracco; Alda Alfarano; Vincenza Martini; Giuseppe Cimino; Pietro Martino; Corrado Girmenia
Journal: J Clin Microbiol Date: 2006-09 Impact factor: 5.948

5. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.

Authors: J Maertens; O Marchetti; R Herbrecht; O A Cornely; U Flückiger; P Frêre; B Gachot; W J Heinz; C Lass-Flörl; P Ribaud; A Thiebaut; C Cordonnier
Journal: Bone Marrow Transplant Date: 2010-07-26 Impact factor: 5.483

6. Rat monoclonal antibodies against Aspergillus galactomannan.

Authors: D Stynen; J Sarfati; A Goris; M C Prévost; M Lesourd; H Kamphuis; V Darras; J P Latgé
Journal: Infect Immun Date: 1992-06 Impact factor: 3.441

7. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors: Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal: Clin Infect Dis Date: 2008-06-15 Impact factor: 9.079

Review 8. Human protothecosis.

Authors: Cornelia Lass-Flörl; Astrid Mayr
Journal: Clin Microbiol Rev Date: 2007-04 Impact factor: 26.132